• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Total number of collaborations and working groups in the quarter

Dictionary: NCTR encourages its employees to engage with scientists across FDA and other government agencies, industry, and academia in cooperative learning to strengthen the scientific foundations vital to developing sound regulatory policy and leveraging resources in order to promote the international standardization and global harmonization of regulatory science.

As working groups and collaborations are established, the more information (e.g., research, results, findings, protocols, etc.), can be shared and leveraged across NCTR's internal and external stakeholders and utilized to develop/enhance better research methods and tools. (1) (2)

Information is current as of December 31, 2013.

Fiscal Year - 2010

Skip graphic and jump to text data

TimeTargetNumber
Oct - Dec 2009N/A37
Jan - Mar 2010N/A247
Apr - Jun 2010N/A236
Jul - Sep 2010N/A215

FY 2010 Overall: 735

Footnotes

  • (1) The FY10 Total is the total of data provided in FY 2010. Note that this may not include all 12 months due to data collection limitations when implementing FDA-TRACK.
  • (2) December 2009 data incorporates only the pilot division data, Division of Neurotoxicity.

Number of collaborative scientific working groups with a NCTR representative in the quarter

Fiscal Year - 2010
Skip graphic and jump to text data.

TimeTargetNumber
Oct - Dec 2009N/A6
Jan - Mar 2010N/A82
Apr - Jun 2010N/A91
Jul - Sep 2010N/A104

FY 2010 Total: 283

Number of presentations conducted with external stakeholders in the quarter

Fiscal Year - 2010
Skip graphic and jump to text data.

TimeTargetNumber
Oct - Dec 2009N/A21
Jan - Mar 2010N/A102
Apr - Jun 2010N/A94
Jul - Sep 2010N/A73

FY 2010 Total: 290

Number of manuscripts submitted to peer-reviewed journals in the quarter

Fiscal Year - 2010
Skip graphic and jump to text data.

TimeTargetNumber
Oct - Dec 2009N/A10
Jan - Mar 2010N/A63
Apr - Jun 2010N/A51
Jul - Sep 2010N/A38

FY 2010 Total: 162

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.